A Cyprus hospital will use VeChain’s blockchain to store all of the COVID-19 test results as we are reading more in the following VeChain news today.
The Blockchain tracking platform VeChain announced on Twitter on June 20 that the blockchain-based medical management platform is working on a new digital healthcare solution from I-Dante which has gone live and will store all of the results from COVID-19 tests results. The platform, E-NewHEalthLife, was deployed in the Mediterranean Hospital in the Republic of Cyprus.
The Cyprus Hospital a special COVID laboratory where the people go and get real-time diagnostic and antibodies testing which will then store the medical tests and records on the blockchain. The records will be encrypted and uploaded on the VeChain Thor Blockchain. The results will also be available on the E-HCert application which will reduce the cost of data storage and sharing. E-HCert App shows immutable test results and lets the users have full control over the data and medical records.
Once the test is finished, people can access their results through the app and it can also be used to prove the health status as well. With the E-HCert records, people in the country can comply with the local quarantine regulations in order for them to work, flight abroad, and get authorization for other activities. Also, The German Federal Office for IT Security recently published a report that recognizes VeChain and its great technology. The study described that the platform has many partners in different branches of the industry thanks to its advanced technology.
The study aimed to examine and to evaluate the security of the top 300 blockchains as a part of market analysis. The study also identified possible fields of application for the projects evaluated. The study had 4 criteria including the number of security incidents, security, evaluability, and how relevant the blockchain is on the market. The study recognized 8 blockchains of the top 300 studied and in addition to Vechain, EOS and Corda were among the top ones.
As per the recent reports, Vechain could soon become the sole beneficiary of the “Coinbase Effect” as the American-based exchange considers listing the token on the platform. However, a few technical indexes suggest that VeChain prepares for a correction. If validated, the blockchain-based supply chain management token could even reach $0.007 and $0.006.
DC Forecasts is a leader in many crypto news categories, striving for the highest journalistic standards and abiding by a strict set of editorial policies. If you are interested to offer your expertise or contribute to our news website, feel free to contact us at [email protected]
Stefan has been writing articles for DCForecasts since 2016 in-house full time. As one of our main cryptocurrency writers, he focuses on covering the latest cryptocurrency news, technical charts, price analyses of coins and press releases. When he is not exploring and covering the latest topics in crypto, you can find Stefan playing basketball, tennis or cycling.
DC Forecasts - Newsletter and get recent news directly to your inbox! Daily Newsletter Bitcoin NewsAltcoin NewsLitecoin NewsEthereum NewsBlockchain NewsBitcoin ScamsRegulationExpert AnalysisPress ReleasesCardano NewsRipple NewsLibra NewsBitcoin Cash NewsTron NewsNexo NewsVechain NewsStellar NewsTezos NewsBinance Coin NewsCoinbase NewsChainLink NewsEOS NewsIOTA NewsTether NewsBitcoin SV NewsMonero NewsEthereum Classic NewsDash NewsUNUS NewsCosmos NewsMECX Token NewsNEO NewsDC Forecasts Announcements
Daily Newsletter Bitcoin NewsAltcoin NewsLitecoin NewsEthereum NewsBlockchain NewsBitcoin ScamsRegulationExpert AnalysisPress ReleasesCardano NewsRipple NewsLibra NewsBitcoin Cash NewsTron NewsNexo NewsVechain NewsStellar NewsTezos NewsBinance Coin NewsCoinbase NewsChainLink NewsEOS NewsIOTA NewsTether NewsBitcoin SV NewsMonero NewsEthereum Classic NewsDash NewsUNUS NewsCosmos NewsMECX Token NewsNEO NewsDC Forecasts Announcements
DC Forecasts provides a comprehensive source of the latest news about cryptocurrency news daily. Read more on our about us page for details.